Participated · Series A · Jul 2026

Natural builds payment infrastructure that lets autonomous AI agents execute financial actions such as paying vendors, collecting payments, and transacting with other agents or humans. The startup redesigns financial rails to support agent-initiated transactions that traditional systems (credit cards, ACH) were not built for. Founded in 2025 by Kahlil Lalji with co-founders including Eric Wang and Walt Leung, Natural has operated in beta while making core architectural decisions. The company plans to support both traditional bank payments and USD-backed stablecoins as part of its architecture. Natural has attracted senior talent from fintech firms like Stripe, Ramp, and Square to accelerate product development. With $40 million in total funding after the Series A, the company is positioning itself to compete with incumbents such as Stripe and emerging rivals in the agentic payments space.

Participated · Seed · Jun 2026

F2 provides an agentic workflow platform for private markets that transforms deal history into a persistent, queryable knowledge asset and automates screening, underwriting, and portfolio monitoring. Its product suite—built around Adam, Deal Intelligence, and Institutional Knowledge—includes an Excel-native financial analysis engine, auditable layers, and agents that carry context across a firm’s deal universe. The platform is multi-model, leveraging Opus 4.8, ChatGPT 5.5, Gemini 3.5 Flash, and Microsoft Office Suite native LLM tools, and emphasizes enterprise-grade data privacy with zeroday data retention by LLMs. F2 is deployed across more than 100 private credit funds and banks and counts customers such as Jefferies Credit Partners, Bain Capital, and Live Oak Bank. Key metrics cited include a 650% increase in monthly active users and over 15,000 deals analyzed since the start of the year. The company plans continued product expansion (including Portfolio Monitoring) and global hiring to support enterprise deployments. Headquartered in New York City, F2 is backed by HighlandX, Left Lane Capital, NFX, Y Combinator, and Torch Capital.

Participated · Series C · Feb 2026

Solace provides a patient-centric advocacy layer that operates alongside clinical care, pairing individuals with experienced nurses and care specialists who coordinate appointments, manage logistics, and surface treatment options. Accessible via a HIPAA-compliant text, phone, and video platform, the company currently supports more than 20,000 patients each month and works with a national network of over 2,000 professional advocates. Founded in 2022 by CEO Jeremy Gurewitz and Chief Product Officer Sara Sargent, Solace addresses the costly gaps between diagnosis and treatment that leave nearly 40% of Americans delaying or avoiding care. The company reports 10× year-over-year growth, underscoring rising demand as healthcare complexity and costs climb. Revenue figures are not disclosed, but the business is now valued at more than $1 billion following its latest round. With fresh capital, Solace plans to scale its advocate network, invest further in its technology platform and clinical research, and deepen partnerships with payers and providers to embed advocacy earlier in the care journey.

Participated · Series A · Jan 2026

Salvo Health offers brick-and-mortar gastrointestinal (GI) clinics a continuous virtual care platform that connects patients with a specialized, gut-focused care team. Users gain direct, ongoing access to registered dietitians, behavioral-health professionals, and nurses, helping clinics save time, boost revenue, and improve outcomes. In 2025 the company reported 800% year-over-year growth in both patients and revenue and expanded enterprise agreements with GI doctors by more than 1,000%, reaching 801 signed GI partners. Led by CEO Jeffrey Glueck, COO Marin Rothenberg, and CMO Dr. Erin Hendriks, the company is now building an AI-driven product roadmap. The new funding will finance engineering expansion and nationwide hiring of additional clinical staff to meet rising demand. Salvo Health positions itself at the intersection of virtual specialty care and chronic condition management, with ambitions to scale its platform nationally.

Participated · Seed · Dec 2025

Supper provides a self-serve data platform that integrates directly with SaaS tools and data warehouses, automatically cleanses and normalizes information, and builds a semantic layer so anyone at a company can query data in plain language. Its agent suite can answer business questions, construct complex dashboards, and support research projects, eliminating the need for engineers and analysts to handle ad-hoc SQL requests. Early customers report saving 7–8 engineering hours per week thanks to the product’s automation. Co-founded by Lowell Putnam (previously founded Quovo, acquired by Plaid) and Andrew Salamon (co-founder of Hims & Hers), the New York-based startup targets high-growth companies that struggle with fragmented, unreliable data access. The founders emphasize a “simple on the surface, powerful under the hood” approach that strengthens trust in analytics and speeds decision-making. With fresh seed funding, Supper plans to accelerate product development and broaden its customer base, continuing its mission to make data access effortless, fast, and reliable.